Pro investoryPro médiaCOVID-19
  1. Home
  2. Zobrazovací technika
  3. ClearCEM
MAMMOMAT B.brilliant Key Visual

ClearCEMA new era in contrast-enhanced mammography

Our new recombination algorithm lifts CEM (contrast-enhanced mammography) breast imaging to a higher, brilliant level: with outstanding image quality, we are setting a new benchmark for accuracy and diagnostic certainty, bringing mammography closer to MRI.

Exceptional image quality

1/2
Low-energy vs. ClearCEM01
Dual-energy mammography01
ClearCEM - Fast identification of potential cancers

ClearCEM
Fast identification of potential cancers

Detect lesions with uncompromised diagnostic confidence thanks to unrivaled ClearCEM image quality. ClearCEM on MAMMOMAT B.brilliant delivers crystal-clear enhancement and consistency, which helps make suspicious areas easy to identify. By generating a more uniform background2, it makes lesions stand out with remarkable brilliance.

ClearCEM - Fast identification of potential cancers
ClearCEM - Dual-energy mammography: the base for ClearCEM
1/2

Clinical indications

Dense breast tissue – a challenge for cancer detection

The anatomical structure of a dense breast makes the identification of lesion or microcalcification much harder. With ClearCEM images, breast lesion stands out from the surrounding tissue and will thus help radiologists evaluate the likelihood of malignancy.

Graphic showing dense breast tissue – a challenge for cancer detection

    Cost-effective workflow

    Quick and convenient ClearCEM workflow for fast results

    ClearCEM can help reduce the need for MRI – saving time, cost, and capacity – and enables to retain the reassurance and comfort of familiar procedures and personnel.

    System design of MAMMOMAT B.brilliant helps reduce tube overheating


    This means that unnecessary delays for both patients and technologists are prevented. At the same time the image quality-dose-ratio is optimized, the time-to-diagnosis is shortened5, and patient throughput can be increased6.

    A physician talks to a patient before the contrast-enhanced mammography examination with the MAMMOMAT B.brilliant.

    Clinical evidence

    1/4
    Case 101
    Case 201
    Case 301
    Case 401
    ClearCEM clinical case: Invasive ductal carcinoma

    Case 1
    Invasive ductal carcinoma

    Age 63
    Density B
    BI-RADS 6
    Diagnosis: IDC
    Laterality: right
    Enhancement, spiculated mass
    Mild BPE

    ClearCEM clinical case: Invasive ductal carcinoma
    ClearCEM clinical case: Multifocal invasive lobular cancer
    ClearCEM clinical case: Ductal carcinoma in situ
    ClearCEM clinical case: Invasive ductal carcinoma
    1/4
    ClearCEM is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed.  

    Any technical data contained on this website may vary within defined tolerances. Original images always lose a certain amount of detail when reproduced.
    ​2
    Data on file, compared to VA10, MAMMOMAT B.brilliant
    ​3
    Kerlikowske K, Ichikawa L, Miglioretti DL, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 2007;99:386-395.
    ​4
    Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammo graphically dense breasts in the United States. J Natl Cancer Inst 2014;106(10):dju255.
    5
    Compared to MRI